Landiololhydrochlorid (1) – Rapibloc®
Tachycardia, atrial fibrillation or atrial flutter
Characteristics
| Start date | 12.06.2017 |
|---|---|
| Resolution | 19.10.2017 |
| INN | Landiololhydrochlorid |
| Brand name | Rapibloc® |
| Pharm. company | Amomed Pharma GmbH |
| G-BA Procedure ID | F-001w |
| ATC code | C07AB14 Beta blocking agents, selective (C07AB) |
| Therapeutic area | Cardiovascular diseases |
| Reason for procedure | not completed: exempted |
Associated procedures
<< List of all resolutions